Study directory

Bipolarity studies

Compare studies and check their requirements with the research team.

Back to overview

1909studies shown

Showing 1,081-1,092 of 1,909

CompletedNCT00616889

Effect of Quetiapine on Sleep Architecture in Depression in bipolarity and Major Depressive Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In Kingston

Why is this study shown?

This study includes Bipolarity among several conditions.

Depression, BipolarityDrugFrom 18 Years to 65 Years

Countries: Canada
Sponsor: Queen's University
Condition: Depression, Bipolarity

View study

CompletedNCT00595387

Effectiveness of Cognitive Behavioral Therapy for Treating Depression in People With Bipolarity type I

This summary needs review. Please check the official study record and contact the research team for details.

In Boston

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionBehavioralFrom 18 Years to 64 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: Bipolarity, Depression

View study

WithdrawnNCT03629106

Effects of Cannabis Abstinence on Symptomology and Cognition in Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Toronto

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, AddictionBehavioralFrom 18 Years to 60 Years

Countries: Canada
Sponsor: Centre for Addiction and Mental Health
Condition: Bipolarity, Addiction

View study

WithdrawnNCT01557933

Effects of Electroconvulsive Therapy (ECT) in Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionObservationalFrom 18 Years to 55 Years

Countries
Sponsor: Mclean Hospital
Condition: Bipolarity, Depression

View study

CompletedNCT00216723

Aripiprazole for schizophrenia

This study is completed in South Korea. It is testing aripiprazole for schizophrenia.

In Seoul

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, SchizophreniaDrugFrom 18 Years to 80 Years

Countries: South Korea
Sponsor: Korea Otsuka Pharmaceutical Co., Ltd.
Condition: Bipolarity, Schizophrenia

View study

TerminatedNCT00771134

Lu AA39959 for depression in bipolarity

This study was terminated in the United States. It is testing Lu AA39959 for depression in bipolarity.

In Atlanta

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: H. Lundbeck A/S
Condition: Bipolarity, Depression

View study

WithdrawnNCT01587066

Efficacy of Quetiapine XR Versus Divalproex on Clinical Outcome Quality of Sleep and Quality of Life for depression in bipolarity

This study was withdrawn in South Korea. It is testing Efficacy of Quetiapine XR Versus Divalproex on Clinical Outcome Quality of Sleep and Quality of Life for depression in bipolarity.

In Naju

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 20 Years to 65 Years

Countries: South Korea
Sponsor: Bo-Hyun Yoon
Condition: Bipolarity, Depression

View study

TerminatedNCT02749006

Efficacy of rTMS in Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Calgary

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDeviceFrom 18 Years to 70 Years

Countries: Canada
Sponsor: University of British Columbia
Condition: Bipolarity, Depression

View study

TerminatedNCT01093963

Efficacy Study of Lisdexamfetamine to Treat Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Mason

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Lindner Center of HOPE
Condition: Bipolarity, Depression

View study

CompletedNCT03965871

Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Bełchatów

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: Poland
Sponsor: Celon Pharma SA
Condition: Bipolarity, Depression

View study

TerminatedNCT00464191

Escitalopram for depression in bipolarity

This study was terminated in Norway. It is testing escitalopram for depression in bipolarity.

In Nordfjordeid

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 70 Years

Countries: Norway
Sponsor: Nordfjord Psychiatric Centre
Condition: Bipolarity, Depression

View study

CompletedNCT01256177

Quetiapine Fumarate Extended Release for depression in bipolarity

This study is completed in China. It is testing quetiapine Fumarate Extended Release for depression in bipolarity.

Multiple locations, including Baoding

Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: China
Sponsor: AstraZeneca
Condition: Bipolarity, Depression

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.